Table 2 Mean patient co-payments by funding model and CSC status 2001/02-2004/05
Funding Type | Age | CSC | 2001/02 | 2002/03 | 2003/04 | 2004/05 | Change 2001/02-2002/03 | Change 2002/03-2003/04 | Change 2003/04-2004/05 | Change Whole Period 2001/02-2004/05 |
|---|---|---|---|---|---|---|---|---|---|---|
Access | 0–5 | N | 0.74 | 0.66 | 0.49 | 0.7 | -0.08 (-11%) | -0.17 (-26%) | 0.21 (43%) | -0.04 (-5%) |
| Â | Â | Y | 0.37 | 0.32 | 0.25 | 0.33 | -0.05 (-14%) | -0.07 (-22%) | 0.08 (32%) | -0.04 (-11%) |
|  | 6–17 | N | 12.47 | 13.81 | 10.9 | 9.23 | 1.34 (11%) | -2.91 (-21%) | -1.67 (-15%) | -3.24 (-26%) |
| Â | Â | Y | 7.22 | 7.72 | 6.77 | 6.34 | 0.50 (7%) | -0.95 (-12%) | -0.43 (-6%) | -0.88 (-12%) |
|  | 18–24 | N | 23.2 | 24.6 | 17.44 | 17.09 | 1.40 (6%) | -7.16 (-29%) | -0.35 (-2%) | -6.11 (-26%) |
| Â | Â | Y | 17 | 16.57 | 13.6 | 13.85 | -0.43 (-3%) | -2.97 (-18%) | 0.25 (2%) | -3.15 (-19%) |
|  | 25–44 | N | 26.17 | 26.11 | 19.88 | 19.75 | -0.06 (0%) | -6.23 (-24%) | -0.13 (-1%) | -6.42 (-25%) |
| Â | Â | Y | 15.93 | 15.57 | 13.24 | 13.91 | -0.36 (-2%) | -2.33 (-15%) | 0.67 (5%) | -2.02 (-13%) |
|  | 45–64 | N | 25.54 | 25.33 | 19.43 | 19.22 | -0.21 (-1%) | -5.90 (-23%) | -0.21 (-1%) | -6.32 (-25%) |
| Â | Â | Y | 16.43 | 16.25 | 14.04 | 14.14 | -0.18 (-1%) | -2.21 (-14%) | 0.10 (1%) | -2.29 (-14%) |
| Â | 65+ | N | 24.77 | 25 | 19.88 | 16.1 | 0.23 (1%) | -5.12 (-20%) | -3.78 (-19%) | -8.67 (-35%) |
| Â | Â | Y | 15.8 | 16.65 | 15.03 | 14.08 | 0.85 (5%) | -1.62 (-10%) | -0.95 (-6%) | -1.72 (-11%) |
Interim | 0–5 | N | 1.64 | 2 | 2.61 | 3.33 | 0.36 (22%) | 0.61 (31%) | 0.72 (28%) | 1.69 (103%) |
| Â | Â | Y | 0.93 | 0.94 | 1.08 | 1.59 | 0.01 (1%) | 0.14 (15%) | 0.51 (47%) | 0.66 (71%) |
|  | 6–17 | N | 16.95 | 18.26 | 19.06 | 18.75 | 1.31 (8%) | 0.80 (4%) | -0.31 (-2%) | 1.80 (11%) |
| Â | Â | Y | 12.5 | 13.26 | 14.43 | 14.91 | 0.76 (6%) | 1.17 (9%) | 0.48 (3%) | 2.41 (19%) |
|  | 18–24 | N | 32.69 | 35.01 | 36.76 | 37.02 | 2.32 (7%) | 1.75 (5%) | 0.26 (1%) | 4.33 (13%) |
| Â | Â | Y | 26.04 | 27.19 | 29.02 | 30.01 | 1.15 (4%) | 1.83 (7%) | 0.99 (3%) | 3.97 (15%) |
|  | 25–44 | N | 33.95 | 35.99 | 37.51 | 39.08 | 2.04 (6%) | 1.52 (4%) | 1.57 (4%) | 5.13 (15%) |
| Â | Â | Y | 24.42 | 25.52 | 27.5 | 29.44 | 1.10 (5%) | 1.98 (8%) | 1.94 (7%) | 5.02 (21%) |
|  | 45–64 | N | 33.17 | 34.3 | 35.57 | 37.04 | 1.13 (3%) | 1.27 (4%) | 1.47 (4%) | 3.87 (12%) |
| Â | Â | Y | 23.39 | 24.09 | 25.65 | 26.82 | 0.70 (3%) | 1.56 (6%) | 1.17 (5%) | 3.43 (15%) |
| Â | 65+ | N | 30.99 | 32.21 | 33.01 | 22.84 | 1.22 (4%) | 0.80 (2%) | -10.17 (-31%) | -8.15 (-26%) |
| Â | Â | Y | 20.59 | 21.77 | 23.09 | 20.4 | 1.18 (6%) | 1.32 (6%) | -2.69 (-12%) | -0.19 (-1%) |